[Value of cholestyramine in the treatment of refractory diarrhea in infants and the newborn].
D000138:Acidosis / Q000139:chemically induced; D001419:Bacteria / Q000187:drug effects; D001647:Bile Acids and Salts / Q000378:metabolism; D002446:Celiac Disease / Q000139:chemically induced; D002792:Cholestyramine Resin / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003248:Constipation / Q000139:chemically induced; D003968:Diarrhea, Infantile / Q000188:drug therapy*; D004731:Endotoxins / Q000378:metabolism; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011041:Poisoning / Q000188:drug therapy
D001647:Bile Acids and Salts; D004731:Endotoxins; D002792:Cholestyramine Resin
Intérêt de la cholestyramine dans le traitement des diarrhées rebelles du nourrisson et du nouveau-né